methylprednisolone and rolipram

methylprednisolone has been researched along with rolipram in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Appel, K; Boddeke, HW; Buttini, M; Gebicke-Haerter, PJ; Limonta, S; Mir, A; Wiederhold, KH1
Briggs, WA; Burdick, J; Choi, M; Orgul, O; Scheel, PJ; Wu, Q1
Guarner, F; Malagelada, JR; Medina, C; Mourelle, M; Salas, A; Videla, S; Vilaseca, J1
Cui, H; Deng, L; Li, Z; Sun, W; Xiang, J; Xie, P; Yin, Y; Zhang, B; Zou, J1

Other Studies

5 other study(ies) available for methylprednisolone and rolipram

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: inhibition by methylprednisolone and by rolipram.
    British journal of pharmacology, 1997, Volume: 122, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Brain; In Situ Hybridization; Injections, Intraperitoneal; Lipopolysaccharides; Male; Methylprednisolone; Pyrrolidinones; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rolipram; Tumor Necrosis Factor-alpha

1997
Lymphocyte suppression by rolipram with other immunosuppressive drugs.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:8

    Topics: Adult; Aged; Cell Division; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Leukocytes, Mononuclear; Lymphocytes; Male; Methylprednisolone; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Tacrolimus; Thymidine; Tritium

1999
Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Chronic Disease; Colitis; Colon; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Fibrosis; Male; Methylprednisolone; Peroxidase; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2006
Effects of combining methylprednisolone with rolipram on functional recovery in adult rats following spinal cord injury.
    Neurochemistry international, 2013, Volume: 62, Issue:7

    Topics: Animals; Axons; Disease Models, Animal; Female; Methylprednisolone; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Recovery of Function; Rolipram; Spinal Cord Injuries

2013